Chronic Fatigue Syndrome, also known as Myalgic Encephalomyelitis (CFS/ME), is a complex and debilitating condition characterized by extreme fatigue that cannot be explained by any underlying medical condition. The prevalence of CFS/ME varies across different populations and studies, making it challenging to determine an exact figure. However, it is estimated that approximately 0.2% to 2.5% of the global population may be affected by this condition.
CFS/ME can affect individuals of all ages, genders, and ethnicities, although it is more commonly reported in women. The condition often begins in early adulthood and can persist for many years, significantly impacting a person's quality of life. The exact cause of CFS/ME remains unknown, but it is believed to involve a combination of genetic, environmental, and immunological factors.
Diagnosis of CFS/ME can be challenging due to the absence of specific diagnostic tests. Healthcare professionals rely on a thorough evaluation of symptoms, medical history, and ruling out other potential causes of fatigue. Treatment for CFS/ME primarily focuses on managing symptoms and improving overall well-being through a multidisciplinary approach involving rest, pacing, cognitive-behavioral therapy, and symptom-specific medications.
It is important to raise awareness about CFS/ME to ensure timely diagnosis, appropriate support, and further research to better understand and address this debilitating condition.